Clot-dissolving drug administered to greater variety of patients, still not fully utilized

Use of the "clot-busting" drug tissue plasminogen activator (tPA) to treat patients with strokes caused by a blockage of blood flow nearly doubled between 2003 and 2011. In their paper receiving online release in the journal Circulation: Cardiovascular Quality and Outcomes, a team of researchers reports both an overall increase in the use of tPA to dissolve clots blocking arteries supplying the brain and administration of the potentially life-saving drug to a more diverse group of patients...

Source: http://feedproxy.google.com/~r/mnt/healthnews/~3/zKWXH8FpBDY/265124.php

sport sport medical sport news